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Lesson of the week
Assessing the severity of malaria
David A J Moore, Richard M Jennings, Tom F Doherty, Diana N Lockwood, Peter L Chiodini,
Stephen G Wright, Christopher J M Whitty
Malaria caused by infection with Plasmodium falciparum
kills over 1 million people a year.1 In 2000, 1592
confirmed cases were reported to the United
Kingdom’s Malaria Reference Laboratory; 16 of these
people died (John Williams, personal communication,
2002). Guidelines have been published to identify
patients with poor prognostic signs.2–4 A recent study
suggested that patients infected with P falciparum who
present with uncomplicated disease may be treated
safely outside hospital5; however, patients not uncom-
monly present without adverse signs but deteriorate
over the next 24-48 hours despite apparently adequate
treatment. This deterioration occurs because P
falciparum undergoes repeated cycles of maturation
approximately every 48 hours4: only the schizonts
(mature forms) of the parasite sequester and cause
pathology, while the trophozoites (immature forms)
are relatively insensitive to antimalarial treatment.6 We
present two cases from the Hospital for Tropical
Diseases that illustrate why the severity of falciparum
malaria may be underestimated at presentation.
Case reports
Case 1
A 62 year old white man presented with a four day
history of fever 19 days after returning from a two
week holiday in Mozambique. He reported taking
chloroquine 600 mg weekly and proguanil 200 mg
daily as prophylaxis. On admission, he was febrile
(38.4°C), with a pulse of 104 bpm, but examination
was otherwise unremarkable. His blood film showed
trophozoites and schizonts of P falciparum and parasi-
taemia of 2.9%. His haemoglobin was 12.2 g/dl
(normal range 11.5-15.5 g/dl), white cell count
3.6×109/l (3.0×109/l-10.0×109/l), and platelets
20×109/l (150×109/l-400×109/l), and his concentra-
tions of creatinine, electrolytes, and bilirubin and his
chest radiographs were normal. Two hours after he
was admitted to hospital, he became drowsy, confused,
and dysphasic. His blood sugar concentration was 3.8
mmol/l, and he did not respond to a bolus injection of
50% glucose solution. He was transferred to the inten-
sive care unit at our hospital and was treated with
intravenous quinine. His subsequent course was com-
plicated by acute lung injury that required ventilation,
marked haemolysis (lowest haemoglobin 7.4 g/dl),
thrombocytopenia (lowest platelet count 9×109/l), and
a peak parasitaemia of 5.2%. The patient recovered
fully and was discharged 10 days later.
Case 2
A 17 year old woman, who was born in Nigeria but had
been resident in the United Kingdom for several years,
presented with a two day history of fever and vomiting.
She had returned from a three week visit to Nigeria
two days earlier, for which she had taken no malarial
prophylaxis. She appeared well but was mildly
jaundiced and had a temperature of 38.2°C and a pulse
of 110 bpm. Examination was otherwise unremarkable.
A blood film showed trophozoites of P falciparum and
parasitaemia of 1.2%. Further investigations showed
haemoglobin of 13.9 g/dl, white blood cell count
6.2×109/l, platelet count 60×109/l (a normal finding in
patients with malaria), and normal electrolytes and
creatinine. Bilirubin was 84 mol/l (normal < 17). A
pregnancy test was negative, and a chest radiograph
was normal. She was admitted and treated with oral
quinine 600 mg every eight hours.
The next day the patient’s clinical condition was
unchanged, but her parasitaemia had increased to
30%. Her haemoglobin concentration had decreased
to 10.9 g/dl and her platelet count to 35×109/l, while
her bilirubin and creatinine concentrations had
increased to 136 and 279 mol/l. Her treatment was
changed to intravenous quinine 600 mg every 12
hours, and she was transferred to the local intensive
care unit. After 24 hours, the patient’s score on the
Glasgow coma scale had decreased to 11 from 15 (out
of 15), and she was transferred to our hospital.
Although the patient’s parasitaemia had decreased to
0.2%, she developed metabolic acidosis and, within 24
hours, her Glasgow coma score decreased to 8 and she
developed a fixed gaze palsy. Scans from computed
tomography of her brain were unremarkable. She had
to be intubated and ventilated for four days because of
coma and needed haemofiltration for two days
because of acute renal failure (peak creatinine 445
mol/l). Her subsequent recovery was complicated by
a ventilator associated pneumonia. She was dis-
charged on day 10 after admission after making a
full recovery.
Discussion
Patients who look well on presentation with most
infectious diseases seldom deteriorate significantly
once treatment is started. Malaria is much less easy to
assess. The cases described were complicated variously
by cerebral malaria, acute renal failure, marked
haemolysis, metabolic acidosis, acute lung injury with
respiratory failure, and progression to hyperparasit-
aemia despite appropriate chemotherapy. All are well
known complications of P falciparum infection,1 but
the complicated course could not be predicted at
presentation. The two cases are typical of patients seen
at our hospital (and other tropical medicine units),
who appear well and have few, or occasionally no,
signs of severe disease at presentation but subse-
quently deteriorate despite treatment. If either of the
cases described had been sent home from the
emergency department to complete a course of oral
treatment, the outcome probably would have been less
favourable.
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These cases illustrate three common pitfalls. Firstly,
most doctors are aware that severe malaria can occur
with low parasitaemia because the peripheral parasite
count may not accurately reflect the total parasite
load—many late stage parasites are sequestered in the
kidneys, brain, and other organs.7 8 A significant
increase in parasitaemia after starting treatment is
common, however, because of the nature of the
parasite’s life cycle. A mature schizont of P falciparum
contains 8-32 merozoites and within 48 hours of the
mature schizont rupturing, each merozoite is capable
of invading a fresh erythrocyte and developing into a
mature schizont. The potential for a massive surge in
parasitaemia, which may occur after therapy has
started in patients with parasites of roughly the same
age, is clear. Of the last 500 patients treated for
falciparum malaria at our hospital, in the days after
treatment was started, parasitaemia increased above
the values at presentation in 119 (23.8%) cases; in sev-
eral cases, parasitaemia increased several fold. This
problem is compounded because the early ring stages
of the parasite are less sensitive to conventional
antimalarial drugs, including quinine, so sequestration
can occur after treatment is started.
Secondly, a patient with P falciparum who seems
well and whose haematological and biochemical inves-
tigations at presentation are normal or near normal
can be deceptive. Complications of malaria in adults,
especially renal failure and acute lung injury, can occur
after several days when the number of parasites has
decreased from baseline—or even when parasites have
disappeared from the peripheral blood—and when the
patient seems to be improving clinically in other ways.1
Thirdly, patients and their doctors commonly
assume that people brought up in regions in which
malaria is endemic are likely to be immune to the dis-
ease. Immunity to malaria only occurs in some areas,
however, and it wanes if patients are not re-exposed
constantly, so judging an individual’s immunity from
their history (or worse still their ethnicity) is foolhardy.
Adults with malaria who grew up in parts of Africa
where malaria is endemic are common in our intensive
care unit. As it is not easy to judge the likely course of
falciparum malaria reliably at presentation, it is
prudent to admit to hospital all cases of infection with
P falciparum that present in countries in which malaria
is not endemic for at least the initial 48 hours of their
management.
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Where worlds meet
On concluding the midday prayer, the imam turned to the
congregation, which must have numbered over 100 people, and
told them that he had, that morning, been informed that their
friend and fellow worshipper was making good progress in
hospital. Being a visitor to the area, I had no idea to whom he was
referring and paid little attention to the progress report that
followed. The imam’s parting advice did, however, catch my
notice: “There is, therefore, no need for you all to visit him today,
and please pass this message on to your family and friends. Also,
please remember that, when you do go, agree visiting timings
among yourselves so you do not attend all together and cause
unnecessary problems for the nurses and doctors.”
As someone who knows first hand the central importance of
supporting the ill and dying within the Islamic ethic, I fully
appreciate the communal desire for regular visiting that may be
present. My experiences of working on busy hospital wards,
however, have also made me acutely aware of the logistical
difficulties that may result from large visitor numbers and how
these difficulties may be compounded if people visit outside of
the designated visiting times (as many do). The failure to bridge
such differences in perspectives effectively leads to
misunderstanding and resentment, and I have, unfortunately,
witnessed this often. But this need not be the case, for pluralism
can—through mutual sharing of ideas, experiences, and
aspirations—offer penetrating insights into the worlds inhabited
by others. Respectful interaction also offers the potential for
learning new ways of making better sense of our own worlds and,
in so doing, developing new ways of negotiating potential areas of
conflict without necessarily compromising our values.
This small incident impressed me in many ways. I was moved
by the concern so evidently on display for a fellow human in
difficulty. The imam’s advice was thoughtful and, I hoped,
persuasive. Perhaps most impressive of all, however, was the
recognition of the “behind the scenes” discussions and problem
sharing that must have taken place. Inspired, I made a silent
parting prayer for the wellbeing of the invisible actors and
actresses who had momentarily been the centre of my thoughts,
and through whose narrative I had once again been reminded of
the need for, and power of, dialogue.
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We welcome articles up to 600 words on topics such as A memorable
patient, A paper that changed my practice,My most unfortunate mistake,or
any other piece conveying instruction, pathos, or humour. If possible
the article should be supplied on a disk. Permission is needed from
the patient or a relative if an identifiable patient is referred to. We also
welcome contributions for “Endpieces,” consisting of quotations of up
to 80 words (but most are considerably shorter) from any source,
ancient or modern, which have appealed to the reader.
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